Effects of antimicrobial peptide L-K6, a temporin-1CEb analog on oral pathogen growth, Streptococcus mutans biofilm formation, and anti-inflammatory activity

Applied Microbiology and Biotechnology

Volumn 98, Issue 20, 2014, Pages 8685-8695

  Shang, Dejing ^a   Liang, Hao ^a   Wei, Shi ^a   Yan, Xin ^a   Yang, Qingzu ^a   Sun, Yue ^a  

^a LIAONING NORMAL UNIVERSITY   (China)

Author keywords

Amphibian; Antimicrobial peptide; Biofilm; Dental caries; Inflammation; Lipopolysaccharide

Indexed keywords

CELL DEATH; MICROORGANISMS; PEPTIDES;

AMPHIBIAN; ANTIMICROBIAL PEPTIDE; DENTAL CARIES; INFLAMMATION; LIPOPOLYSACCHARIDES;

BIOFILMS;

ANTIINFLAMMATORY AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANTAGONISTS AND INHIBITORS; BIOFILM; CANDIDA ALBICANS; CELL LINE; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; MONOCYTE; PHYSIOLOGY; RANIDAE; STREPTOCOCCUS MUTANS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BIOFILMS; CANDIDA ALBICANS; CELL LINE; INTERLEUKIN-8; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MONOCYTES; RANIDAE; STREPTOCOCCUS MUTANS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84920256643     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-014-5927-9     Document Type: Article

References (44)

1. Ahn SJ, Wen ZT, Brady LJ, Burne RA (2008) Characteristics of biofilm formation by Streptococcus mutans in the presence of saliva. Infect Immun 76:4259–4268
2. Alhede M, Bjarnsholt T, Jensen PO (2009) Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes. Microbiology 155:3500–3508
3. Beckloff N, Laube D, Castro T, Furgang D, Park S, Perlin D, Clements D, Tang H (2007) Activity of an antimicrobial peptide mimetic against planktonic and biofilm cultures of oral pathogens. Antimicrob Agents Chemother 51:4125–4132
4. Concannon SP, Crowe TD, Abercrombie JJ, Molina CM, Hou P, Sukumaran DK, Raj PA, Leung KP (2003) Susceptibility of oral bacteria to an antimicrobial decapeptide. J Med Microbiol 52:1083–1093
5. Costerton W, Veeh R, Shirtliff M, Pasmore M, Post C, Ehrlich G (2003) The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 112:146–147
6. Gilmore K, Chen P, Leung KP (2009) Anti-microbial peptides for plaque control and beyond. J Calif Dent Assoc 37:779–788
7. Graves DT, Cochran D (2003) The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 74:391–401
8. Hamada S, Slade HD (1980) Biology, immunology, and cariogenicity of Streptococcus mutans. Microbiol Rev 44:331–384
9. Herrera D, Alonso B, Leon R, Roldan S, Sanz M (2008) Antimicrobial therapy in periodontitis: the use of systemic antimicrobials against the subgingival biofilm. J Clin Periodontol 35:45–66
10. Kolenbrander PE, Palmer RJ Jr, Rickard AH, Jakubovics NS, Chalmers NI, Diaz PI (2006) Bacterial interactions and successions during plaque development. Periodontol 42:47–79
11. Lai Y, Gallo RL (2009) AMPed Up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol 30:131–141
12. Le Roy D, Morand P, Lengacher S, Celio M, Grau GE, Glauser MP, Heumann D (1996) Streptococcus mitis cell walls and lipopolysaccharide induce lethality in D-galactosamine-sensitized mice by a tumor necrosis factor-dependent pathway. Infect Immun 64:1846–1849
13. Liu Y, Wang L, Zhou X, Hu S, Zhang S, Wu H (2011) Effect of the antimicrobial decapeptide KSL on the growth of oral pathogens and Streptococcus mutans biofilm. Int J Antimicrob Agents 37:33–38
14. MacKay BJ, Denepitiya L, Iacono VJ, Krost SB, Pollock JJ (1984) Growth-inhibitory and bactericidal effects of human parotid salivary histidine-rich polypeptides on Streptococcus mutans. Infect Immun 44:695–701
15. Mant CT, Kovacs JM, Kim HM, Pollock DD, Hodges RS (2009) Intrinsic amino acid side-chain hydrophilicity/hydrophobicity coefficients determined by reversed-phase high-performance liquid chromatography of model peptides: comparison with other hydrophilicity/hydrophobicity scales. Biopolymers 92:573–595
16. Marsh PD (2005) Dental plaque: biological significance of a biofilm and community life-style. J Clin Periodontol 32:7–15
17. Matsuzaki K, Murase O, Fujii N (1996) An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry 35:11361–11368
18. Miyasaki KT, Bodeau AL, Selsted ME, Ganz T, Lehrer RI (1990) Killing of oral, gram-negative, facultative bacteria by the rabbit defensin, NP-1. Oral Microbiol Immunol 5:315–319
19. Miyasaki KT, Iofel R, Lehrer RI (1997) Sensitivity of periodontal pathogens to the bactericidal activity of synthetic protegrins, antibiotic peptides derived from porcine leukocytes. J Dent Res 76:1453–1459
20. Mohanram H, Bhattacharjya S (2014) β-Boomerang antimicrobial and antiendotoxic peptides: lipidation and disulfide bond effects on activity and structure. Pharmaceuticals 7:482–501
21. Monroe D (2007) Looking for chinks in the armor of bacterial biofilms. PLoS Biol 5:307
22. Mosca DA, Hurst MA, So W, Viajar BS, Fujii CA, Falla TJ (2000) IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis. Antimicrob Agents Chemother 44:1803–1808
23. Natanson C, Danner RL, Elin RJ, Hosseini JM, Peart KW, Banks SM, MacVittie TJ, Walker RI, Parrillo JE (1989) Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J Clin Investig 83:243–251
24. Pál T, Abraham B, Sonnevend Á, Juma P, Conlon JM (2006) Brevinin1BYa: a naturally occurring peptide from frog skin with broad-spectrum antibacterial and antifungal properties. Int J Antimicrob Agents 27:525–529
25. Rosenfeld Y, Shai Y (2006) Lipopolysaccharide (endotoxin)-host defense antibacterial peptides interactions: role in bacterial resistance and prevention of sepsis. Biochim Biophys Acta 1758:1513–1522
26. Rosenfeld Y, Papo N, Shai Y (2006) Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action. J Biol Chem 281:1636–1643
27. Sansom MS (1991) The biophysics of peptide models of ion channels. Prog Biophys Mol Biol 55:139–235
28. Sasaki H, White SH (2008) Aggregation behavior of an ultra-pure lipopolysaccharide that stimulates TLR-4 receptors. Biophys J 95:986–993
29. Schmidtchen A, Malmsten M (2013) Peptide interactions with bacterial lipopolysaccharides. Curr Opin Colloid Interface Sci 18:381–392
30. Schuerholz T, Brandenburg K, Marx G (2012) Antimicrobial peptides and their potential application in inflammation and sepsis. Crit Care 16:207–214
31. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ (1990) Structure and function of lipopolysaccharide binding protein. Science 249:1429–1431
32. Scott MG, Vreugdenhil AC, Buurman WA, Hancock RE, Gold MR (2000) Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J Immunol 164:549–553
33. Shai Y (1999) Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta 1462:55–70
34. Shang DJ, Yu F, Li J, Zheng J, Zhang L, Li Y (2009) Molecular cloning of cDNAs encoding antimicrobial peptide precursors from the skin of the Chinese brown frog Rana chensinensis. Zoolog Sci 26:220–226
35. Shang DJ, Li X, Sun Y, Wang C, Sun L, Wei S (2012a) Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, temporin-1CEb from Chinese brown frog, Rana chensinensis. Chem Biol Drug Des 79:653–662
36. Shang DJ, Sun Y, Wang C, Wei S, Ma L, Sun L (2012b) Membrane interaction and antibacterial properties of chensinin-1, an antimicrobial peptide with atypical structural features from the skin of Rana chensinensis. Appl Microbiol Biotechnol 96:1551–1560
37. Sharma S, Khan IA, Ali I, Ali F, Kumar M, Kumar A (2009) Evaluation of the antimicrobial, antioxidant, and anti-inflammatory activities of hydroxychavicol for its potential use as an oral care agent. Antimicrob Agents Chemother 53:216–222
38. Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, Kimoto M (1999) MD-2, a molecule that confers lipopolysaccharide responsiveness on toll-like receptor 4. J Exp Med 189(11):1777–1782
39. Silva BR, Freitas VAA, Nascimento-Neto LG, Carneiro VA, Arruda FVS, Aguiar ASW, Cavada BS, Teixeira EH (2012) Antimicrobial peptide control of pathogenic microorganisms of the oral cavity: a review of the literature. Peptides 36:315–321
40. Stewart PS, Costerton JW (2001) Antibiotic resistance of bacteria in biofilms. Lancet 358:135–138
41. Wei GX, Campagna AN, Bobek LA (2006) Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. J Antimicrob Chemother 57:1100–1109
42. Wei W, Rui T, Tong ZC, Ding YL, Rong K, Zhai SF, Liu J, Nia LX (2012) Effect of a novel antimicrobial peptide chrysophsin-1 on oral pathogens and Streptococcus mutans biofilms. Peptides 33:212–219
43. Wilson M (1996) Susceptibility of oral bacterial biofilms to antimicrobial agents. J Med Microbiol 44:79–87
44. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431–1433